---
title: "Micro-Cap Crossroads: 350% Target Surges Meet Nasdaq Deadlines"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/301693310.md"
description: "Zura Bio's target price soars 350% above current levels as Guggenheim maintains Buy rating; XCUR races against Nasdaq's December 2 delisting deadline; SRx Health pursues strategic acquisitions while East West Bancorp reports 3.48% sequential revenue growth."
datetime: "2026-10-13T10:15:32.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/301693310.md)
  - [en](https://longbridge.com/en/news/301693310.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/301693310.md)
generator: "portal-rs"
---

# Micro-Cap Crossroads: 350% Target Surges Meet Nasdaq Deadlines

Zura Bio (ZURA.US) is making waves with Guggenheim's bullish stance, projecting a target price 351.56% above recent trading levels amid its clinical-stage pipeline for alopecia treatment. Meanwhile, Exicure (XCUR.US) races against Nasdaq's December 2 deadline to restore shareholder equity compliance after receiving delisting warnings in September. SRx Health Solutions (SRXH.US) has quietly built momentum through strategic moves including a Vistagen Therapeutics stake acquisition and CERo financing deal. East West Bancorp (EWBC.US) stands out with Q3 revenue growth of 3.48% and stable net interest margins at 3.93%. UroGen Pharma (URG.US) advanced its urology oncology focus through a Jazz Pharmaceuticals collaboration, while Dun & Bradstreet (DNB.US) reported steady data services expansion. Manitowoc (MANE.US) unveiled new crane models targeting infrastructure demand, Bitcoin ETF (SBIT.US) crossed $1 billion in assets under management, and Mission Broadcasting (MSS.US) completed its Nexstar acquisition. Data Storage Corporation (DTST.US) strengthened enterprise positioning via IBM cloud storage partnerships.

### Related Stocks

- [SRXH.US](https://longbridge.com/en/quote/SRXH.US.md)
- [XCUR.US](https://longbridge.com/en/quote/XCUR.US.md)
- [ZURA.US](https://longbridge.com/en/quote/ZURA.US.md)
- [EWBC.US](https://longbridge.com/en/quote/EWBC.US.md)
- [URG.US](https://longbridge.com/en/quote/URG.US.md)
- [DNB.US](https://longbridge.com/en/quote/DNB.US.md)
- [MANE.US](https://longbridge.com/en/quote/MANE.US.md)
- [SBIT.US](https://longbridge.com/en/quote/SBIT.US.md)
- [MSS.US](https://longbridge.com/en/quote/MSS.US.md)
- [DTST.US](https://longbridge.com/en/quote/DTST.US.md)

## Related News & Research

- [Should Raised NII Guidance Require Action From East West Bancorp Stock Investors?](https://longbridge.com/en/news/302818326.md)
- [East West Bancorp (NASDAQ:EWBC) Posts Earnings Results, Beats Expectations By $0.04 EPS](https://longbridge.com/en/news/302463796.md)
- [KBW Keeps Their Buy Rating on East West Bancorp (EWBC)](https://longbridge.com/en/news/302550781.md)
- [East West Bancorp Earnings Call Signals Robust Growth](https://longbridge.com/en/news/302622806.md)
- [East West Bancorp Q3 revenue beats estimates on loan and deposit growth](https://longbridge.com/en/news/302463071.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**